PrescottJr, William A. Prescott; Doloresco, Fred; … - In: PharmacoEconomics 28 (2010) 4, pp. 279-293
Respiratory syncytial virus (RSV) is the leading cause of infant hospitalization in the US. The economic burden of severe disease is substantial, including hospitalization costs and out-of-pocket expenses. RSV prophylaxis with either RSV immune globulin intravenous (RSV-IGIV) or palivizumab has...